S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:EXPO

Exponent (EXPO) Stock Forecast, Price & News

$87.55
+0.58 (+0.67%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$85.43
$88.48
50-Day Range
$86.02
$111.41
52-Week Range
$83.49
$127.61
Volume
337,777 shs
Average Volume
343,678 shs
Market Capitalization
$4.54 billion
P/E Ratio
46.57
Dividend Yield
1.10%
Beta
0.59
30 days | 90 days | 365 days | Advanced Chart
Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

Exponent logo

About Exponent

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Headlines

Exponent (NASDAQ:EXPO) Stock Price Down 4.7%
See More Headlines

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:EXPO
CUSIP
30214U10
Employees
1,215
Year Founded
1967

Sales & Book Value

Annual Sales
$466.27 million
Cash Flow
$1.89 per share
Book Value
$7.46 per share

Profitability

Net Income
$101.20 million
Pretax Margin
26.87%

Debt

Price-To-Earnings

Miscellaneous

Free Float
50,889,000
Market Cap
$4.54 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 3/25 Dividend
3/10/2022
Dividend Payable
3/25/2022
Last Earnings
4/28/2022
Today
5/21/2022
Ex-Dividend for 6/24 Dividend
6/09/2022
Dividend Payable
6/24/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.64 out of 5 stars

Business Services Sector

56th out of 463 stocks

Management Consulting Services Industry

6th out of 26 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -













Exponent (NASDAQ:EXPO) Frequently Asked Questions

Is Exponent a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Exponent stock.
View analyst ratings for Exponent
or view top-rated stocks.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Exponent
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) announced its quarterly earnings results on Thursday, April, 28th. The business services provider reported $0.56 EPS for the quarter, beating the consensus estimate of $0.52 by $0.04. The business services provider had revenue of $117.90 million for the quarter, compared to analyst estimates of $115.50 million. Exponent had a net margin of 20.90% and a trailing twelve-month return on equity of 25.02%. The company's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.58 earnings per share.
View Exponent's earnings history
.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Thursday, April 28th. Stockholders of record on Friday, June 10th will be given a dividend of $0.24 per share on Friday, June 24th. This represents a $0.96 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date is Thursday, June 9th.
View Exponent's dividend history
.

Is Exponent a good dividend stock?

Exponent pays an annual dividend of $0.96 per share and currently has a dividend yield of 1.10%. Exponent has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Exponent is 51.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Exponent will have a dividend payout ratio of 47.29% next year. This indicates that Exponent will be able to sustain or increase its dividend.
View Exponent's dividend history.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly issued shares were issued to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

1 equities research analysts have issued 1-year target prices for Exponent's stock. Their forecasts range from $120.00 to $120.00. On average, they expect Exponent's share price to reach $120.00 in the next twelve months. This suggests a possible upside of 37.1% from the stock's current price.
View analysts' price targets for Exponent
or view top-rated stocks among Wall Street analysts.

Who are Exponent's key executives?
Exponent's management team includes the following people:
  • Dr. Catherine Ford Corrigan P.E., Ph.D., Pres, CEO & Director (Age 53, Pay $1.36M)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 56, Pay $982.64k)
  • Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E., Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director (Age 53, Pay $818.97k) (LinkedIn Profile)
  • Dr. Bradley A. James Ph.D., P.E., FASM, Corp. VP, Principal Engineer & Practice Director- Materials & Corrosion Engineering (Age 56, Pay $737.77k)
  • Dr. Steven J. Murray P.E., Ph.D., Group VP & Principal Engineer (Age 47, Pay $773.93k) (LinkedIn Profile)
  • Dr. Bernard Ross, Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi, CTO & Principal Engineer (Age 75)
  • Ms. Sally B. Shepard, Chief HR Officer (Age 61)
  • Mr. Eric R. Anderson, VP & Corp. Controller
  • Dr. Robert D. Caligiuri FASM, P.E., Ph.D., Corp. VP of Materials & Corrosion Engineering and Principal Engineer (Age 70)
What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent CEO Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among Exponent's employees.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.18%), Vanguard Group Inc. (10.89%), Conestoga Capital Advisors LLC (4.61%), State Street Corp (3.25%), Geneva Capital Management LLC (2.40%) and Riverbridge Partners LLC (2.14%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, George H Brown, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends for Exponent
.

Which institutional investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Polen Capital Management LLC, Assenagon Asset Management S.A., Goldman Sachs Group Inc., Raymond James & Associates, Arrowstreet Capital Limited Partnership, TD Asset Management Inc., and Sandler Capital Management. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Carol Lindstrom, Harri Kytomaa, Maureen T F Reitman, Paul R Johnston, and Steven J Murray.
View insider buying and selling activity for Exponent
or view top insider-selling stocks.

Which institutional investors are buying Exponent stock?

EXPO stock was purchased by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, State Street Corp, Riverbridge Partners LLC, BlackRock Inc., RK Capital Management LLC, Laurus Investment Counsel Inc., Comerica Bank, and Royal Bank of Canada.
View insider buying and selling activity for Exponent
or or view top insider-buying stocks.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $87.55.

How much money does Exponent make?

Exponent has a market capitalization of $4.54 billion and generates $466.27 million in revenue each year. The business services provider earns $101.20 million in net income (profit) each year or $1.879990 on an earnings per share basis.

How many employees does Exponent have?

Exponent employs 1,215 workers across the globe.

Does Exponent have any subsidiaries?

The following companies are subsidiares of Exponent: Dennis Publishing.

When was Exponent founded?

Exponent was founded in 1967.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at (650) 326-9400, via email at [email protected], or via fax at 650-326-8072.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.